“Golden Ticket” award for HEPHAISTOS from Amgen France and BioLabs Hôtel-Dieu
December 10th, 2024 HEPHAISTOS-Pharma has the honor to be a…
December 10th, 2024 HEPHAISTOS-Pharma has the honor to be a…
November 22th, 2024 HEPHAISTOS-Pharma was laureate of the Hack4Hope, the…
HEPHAISTOS-Pharma welcomes Elaia to complete its Seed Round, securing a…
Our CEO, Frederic CAROFF will be attending BIO-Europe Spring 2024…
HEPHAISTOS-Pharma secures a €2 million seed round with xista science…
🏆 We are pleased to announce that HEPHAISTOS-Pharma has…
The European Medicines Agency (EMA) has granted Orphan Drug Designation…
HEPHAISTOS-Pharma was present at the Event organized by the University…